Eva Macháčková

4.4k total citations
31 papers, 423 citations indexed

About

Eva Macháčková is a scholar working on Genetics, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Eva Macháčková has authored 31 papers receiving a total of 423 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Genetics, 14 papers in Molecular Biology and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Eva Macháčková's work include BRCA gene mutations in cancer (22 papers), Nutrition, Genetics, and Disease (9 papers) and DNA Repair Mechanisms (7 papers). Eva Macháčková is often cited by papers focused on BRCA gene mutations in cancer (22 papers), Nutrition, Genetics, and Disease (9 papers) and DNA Repair Mechanisms (7 papers). Eva Macháčková collaborates with scholars based in Czechia, Belgium and Mexico. Eva Macháčková's co-authors include Lenka Foretová, Marie Navrátilová, Kathleen Claes, Petra Vašíčková, Ilse Coene, Ludwine Messiaen, Bruce Poppe, Anne De Paepe, Dalibor Valík and Marek Svoboda and has published in prestigious journals such as PLoS ONE, Scientific Reports and BMC Cancer.

In The Last Decade

Eva Macháčková

27 papers receiving 404 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eva Macháčková Czechia 11 279 229 87 81 70 31 423
F. B. F. Law Hong Kong 10 242 0.9× 228 1.0× 91 1.0× 127 1.6× 96 1.4× 10 387
Emmanuelle Barouk-Simonet France 4 93 0.3× 160 0.7× 70 0.8× 59 0.7× 72 1.0× 11 287
Virginie Bubien France 5 88 0.3× 147 0.6× 72 0.8× 52 0.6× 69 1.0× 10 266
Katharina Eirich Germany 6 145 0.5× 313 1.4× 34 0.4× 83 1.0× 65 0.9× 8 389
Man Wang China 9 133 0.5× 234 1.0× 29 0.3× 123 1.5× 91 1.3× 12 347
Ian Kesterton United Kingdom 6 137 0.5× 352 1.5× 38 0.4× 128 1.6× 100 1.4× 8 444
Sabine Pagès France 7 380 1.4× 313 1.4× 74 0.9× 96 1.2× 45 0.6× 7 528
Matthew Rowley United States 7 92 0.3× 303 1.3× 22 0.3× 89 1.1× 140 2.0× 7 407
Mara Colombo Italy 10 118 0.4× 156 0.7× 47 0.5× 50 0.6× 36 0.5× 15 250
Dominique Stoppa-Lyonnet France 6 217 0.8× 185 0.8× 40 0.5× 58 0.7× 65 0.9× 6 350

Countries citing papers authored by Eva Macháčková

Since Specialization
Citations

This map shows the geographic impact of Eva Macháčková's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Macháčková with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Macháčková more than expected).

Fields of papers citing papers by Eva Macháčková

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Macháčková. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Macháčková. The network helps show where Eva Macháčková may publish in the future.

Co-authorship network of co-authors of Eva Macháčková

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Macháčková. A scholar is included among the top collaborators of Eva Macháčková based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Macháčková. Eva Macháčková is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Macháčková, Eva, Jana Soukupová, Silvia Petrezsélyová, et al.. (2025). In-frame germline TP53 variant impairs p53 oligomerization and predisposes to cancer. Scientific Reports. 15(1). 30459–30459.
2.
Janatová, Markéta, Eva Macháčková, Jana Soukupová, et al.. (2023). Classification of germline variants identified in cancer predisposition genetic testing – consensus of the CZECANCA consortium. Klinicka onkologie. 36(6). 431–439.
3.
Stolařová, Lenka, Eva Macháčková, Petra Zemánková, et al.. (2020). Identification of Germline Mutations in Melanoma Patients with Early Onset, Double Primary Tumors, or Family Cancer History by NGS Analysis of 217 Genes. Biomedicines. 8(10). 404–404. 13 indexed citations
4.
Soukupová, Jana, Petra Zemánková, Michal Vočka, et al.. (2019). Contribution of Massive Parallel Sequencing to Diagnosis of Hereditary Ovarian Cancer in the Czech Republic. Klinicka onkologie. 32(Suppl 2). 72–78. 1 indexed citations
5.
Macháčková, Eva, Kathleen Claes, Petra Vašíčková, et al.. (2019). Twenty Years of BRCA1 and BRCA2 Molecular Analysis at MMCI – Current Developments for the Classifi cation of Variants. Klinicka onkologie. 32(Suppl 2). 51–71. 11 indexed citations
6.
Soukupová, Jana, Petra Zemánková, Markéta Janatová, et al.. (2018). Validation of CZECANCA (CZEch CAncer paNel for Clinical Application) for targeted NGS-based analysis of hereditary cancer syndromes. PLoS ONE. 13(4). e0195761–e0195761. 18 indexed citations
7.
Foretová, Lenka, Eva Macháčková, Markéta Palácová, et al.. (2016). Recommended Extension of Indication Criteria for Genetic Testing of BRCA1 and BRCA2 Mutations in Hereditary Breast and Ovarian Cancer Syndrome. Klinicka onkologie. 29(Suppl 1). S9–S13. 7 indexed citations
8.
Puchmajerová, Alena, Karel Švojgr, Eva Macháčková, et al.. (2016). Fanconi Anemia, Complementation Group D1 Caused by Biallelic Mutations of BRCA2 Gene – Case Report. Klinicka onkologie. 29(Suppl 1). S89–S92. 1 indexed citations
9.
Švojgr, Karel, David Sumerauer, Alena Puchmajerová, et al.. (2015). Fanconi anemia with biallelic FANCD1/BRCA2 mutations – Case report of a family with three affected children. European Journal of Medical Genetics. 59(3). 152–157. 12 indexed citations
10.
Plevová, Pavlína, et al.. (2013). Breast Cancer in Monozygotic Twins. Klinicka onkologie. 26(3). 213–217. 3 indexed citations
11.
Kleibl, Zdeněk, Ondřej Havránek, Stanislav Kormunda, et al.. (2010). The AIB1 gene polyglutamine repeat length polymorphism and the risk of breast cancer development. Journal of Cancer Research and Clinical Oncology. 137(2). 331–338. 4 indexed citations
12.
Foretová, Lenka, Katarína Petráková, Markéta Palácová, et al.. (2010). Genetic testing and prevention of hereditary cancer at the MMCI--over 10 years of experience.. PubMed. 23(6). 388–400. 6 indexed citations
13.
Macháčková, Eva, Lenka Foretová, Petra Vašíčková, et al.. (2008). Spectrum and characterisation of BRCA1 and BRCA2deleterious mutations in high-risk Czech patients with breast and/or ovarian cancer. BMC Cancer. 8(1). 140–140. 63 indexed citations
14.
Vašíčková, Petra, et al.. (2007). High occurrence of BRCA1 intragenic rearrangements in hereditary breast and ovarian cancer syndrome in the Czech Republic. BMC Medical Genetics. 8(1). 32–32. 48 indexed citations
15.
Foretová, Lenka, Katarína Petráková, Markéta Palácová, et al.. (2006). Genetic and Preventive Services for Hereditary Breast and Ovarian Cancer in the Czech Republic. Hereditary Cancer in Clinical Practice. 4(1). 3–6. 4 indexed citations
16.
Foretová, Lenka, et al.. (2004). BRCA1 and BRCA2 mutations in women with familial or early-onset breast/ovarian cancer in the Czech Republic. Human Mutation. 23(4). 397–398. 60 indexed citations
17.
Claes, Kathleen, Bruce Poppe, Eva Macháčková, et al.. (2003). Differentiating pathogenic mutations from polymorphic alterations in the splice sites of BRCA1 and BRCA2. Genes Chromosomes and Cancer. 37(3). 314–320. 63 indexed citations
18.
Macháčková, Eva. (2003). [Disease-causing mutations versus neutral polymorphism: use of bioinformatics and DNA diagnosis].. PubMed. 142(3). 150–3.
19.
Macháčková, Eva, Jiřı́ Damborský, Dalibor Valík, & Lenka Foretová. (2001). Novel germline BRCA1 and BRCA2 mutations in breast and breast/ovarian cancer families from the Czech Republic. Human Mutation. 18(6). 545–545. 6 indexed citations
20.
Claes, Kathleen, Eva Macháčková, Michel De Vos, et al.. (1999). Mutation Analysis of the BRCA1 and BRCA2 Genes in the Belgian Patient Population and Identification of a Belgian Founder Mutation BRCA1 IVS5+3A>G. Disease Markers. 15(1-3). 69–73. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by F. B. F. Law Breakdown of academic impact, for papers by Emmanuelle Barouk-Simonet Breakdown of academic impact, for papers by Virginie Bubien Breakdown of academic impact, for papers by Katharina Eirich Breakdown of academic impact, for papers by Man Wang Breakdown of academic impact, for papers by Ian Kesterton Breakdown of academic impact, for papers by Sabine Pagès Breakdown of academic impact, for papers by Matthew Rowley Breakdown of academic impact, for papers by Mara Colombo Breakdown of academic impact, for papers by Dominique Stoppa-Lyonnet
Rankless by CCL
2026